26 Jul Cardinal Health Advanced Therapy Solutions
Kelly Kester, Director of Advanced Therapy Solutions
Oct. 12 | 4:15pm | Oxford Biomedica Ballroom
Cardinal Health Advanced Therapy Solutions brings a unique understanding of the challenges of launching and commercializing cell and gene therapies (CGTs) — and how to overcome them effectively. Our early involvement, starting with assisting biopharma in establishing the first CAR-T products in 2017, has enabled us to develop tailored solutions to simplify and streamline the complexities of CGTs. Our clinical and commercial capabilities across the product lifecycle, from regulatory consulting to cryopreservation and shipping, help biopharma companies manage more variables so they can focus on bringing their advanced therapy to patients.